Attached files

file filename
EX-32.2 - EXHIBIT 32-2 - Vitaxel Group Ltds113933_ex32-2.htm
EX-32.1 - EXHIBIT 32-1 - Vitaxel Group Ltds113933_ex32-1.htm
EX-31.2 - EXHIBIT 31-2 - Vitaxel Group Ltds113933_ex31-2.htm
EX-31.1 - EXHIBIT 31-1 - Vitaxel Group Ltds113933_ex31-1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended   September 30, 2018

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______ to _______

 

Commission File Number: 333-201365

 

VITAXEL GROUP LIMITED

(Exact name of registrant as specified in its charter)

 

Nevada   30-0803939
(State or other jurisdiction of incorporation)   (I.R.S. Employer Identification No.)

 

Wisma Ho Wah Genting, No. 35

Jalan Maharajalela, 50150

Kuala Lumpur, Malaysia

(Address of principal executive offices)

 

603.2143.2889

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
   
Non-accelerated filer ☐ (Do not check if a smaller reporting company) Smaller reporting company ☒
  Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

As of November 13, 2018, the registrant had 54,087,903 shares of common stock outstanding.

 

 

 

VITAXEL GROUP LIMITED

 

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED September 30, 2018

TABLE OF CONTENTS

 

    PAGE
     
  PART I - FINANCIAL INFORMATION  
     
Item 1. Financial Statements (unaudited) 3
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 13
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 15
     
Item 4. Controls and Procedures 15
     
  PART II - OTHER INFORMATION  
     
Item 1. Legal Proceedings 16
     
Item 1A. Risk Factors 16
     
Item 2. Unregistered Sales of Equity Securities And Use of Proceeds 16
     
Item 3. Defaults Upon Senior Securities 16
     
Item 4. Mine Safety Disclosures 16
     
Item 5. Other Information 16
     
Item 6. Exhibits 17
     
  SIGNATURES 18

 

 

 

FINANCIAL INFORMATION

 

 ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
    PAGE
     
Condensed Consolidated Balance Sheets   4
     
Condensed Consolidated Statements of Operations and Comprehensive Loss   5
     
Condensed Consolidated Statements of Cash Flows   6
     
Notes to Unaudited Condensed Consolidated Financial Statements   7

 

 3

 

 

VITAXEL GROUP LIMITED 

CONDENSED CONSOLIDATED BALANCE SHEETS

(In U.S. dollars)

 

   September 30,   December 31, 
   2018
(Unaudited)
   2017
(Audited)
 
ASSETS        
Current assets          
Cash and cash equivalents  $2,175,170   $691,199 
Account receivable, net   507     
Amount due from related parties   262,549    136,010 
Inventories   20,395    28,525 
Other receivables, prepayments and other current assets   77,360    44,305 
Total current assets   2,535,981    900,039 
           
Non-current assets          
Long term investments        
Property and equipment, net   209,517    231,058 
Total non-current assets   209,517    231,058 
           
TOTAL ASSETS  $2,745,498   $1,131,097 
           
CURRENT LIABILITIES          
Amounts due to related parties  $5,819,034   $2,370,003 
Commission payables   146,274    152,871 
Accounts payable   17,952    31,406 
Accrued expense and other payables   365,786    492,813 
Total current liabilities   6,349,046    3,047,093 
TOTAL LIABILITIES   6,349,046    3,047,093 
           
Commitments and Contingencies (Note 8(1))          
           
STOCKHOLDERS’ EQUITY          
Preferred stock par value $0.0001: 1,000,000 shares authorized; and 0 outstanding        
Common stock par value $0.0001: 70,000,000 shares authorized; 54,087,903 and 54,087,903 shares issued and outstanding, respectively   5,409    5,409 
Additional paid-in capital   4,749,798    4,749,798 
Accumulated deficit   (8,870,547)   (6,776,474)
Accumulated other comprehensive income   211,791    105,271 
Total stockholders’ equity   (3,603,548)   (1,915,996)
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $2,745,498   $1,131,097 

   

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 4

 

 

VITAXEL GROUP LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

(In U.S. dollars) 

 

   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2018   2017   2018   2017 
REVENUE  $8,250   $13,803   $31,338   $554,149 
                     
COST OF REVENUE   (3,859)   (7,389)   (10, 929)   (185,146)
                     
GROSS PROFIT   4,391    6,414    20,409    369,003 
                     
OPERATING EXPENSES                    
Selling expense   151    (433)   (7,244)   (691)
General and administrative expenses   (325,562)   (290,608)   (1,249,118)   (4,504,102)
Total operating expenses   (325,411)   (291,041)   (1,256,362)   (4,504,793)
                     
LOSS FROM OPERATIONS   (321,020)   (284,627)   (1,235,953)   (4,135,790)
                     
OTHER INCOME/(EXPENSE), NET                    
Other income   160,374    200    154,833    43,630 
Other expense   (592,228)   (24,441)   (712,953)   (24,635)
Total other income / (expense), net   (431,854)   (24,241)   (558,120)   19,195 
                     
Net loss  $(752,873)  $(308,868)  $(1,794,073)  $(4,116,595)
                     
OTHER COMPREHENSIVE LOSS                    
Foreign currency translation adjustment   77,578    214,920    106,520    (12,019)
                     
TOTAL COMPREHENSIVE LOSS  $(675,295)  $(93,948)  $(1,687,552)  $(4,128,614)
                     
Weighted average number of common shares outstanding - basic and diluted   54,087,903    54,087,903    54,087,903    54,087,903 
Net Loss per share - basic and diluted  $0.01   $(0.00)  $(0.03)  $(0.01)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 5

 

 

VITAXEL GROUP LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In U.S. dollars) 

 

   For the Period Ended September 30, 
   2018   2017 
         
CASH FLOWS FROM OPERATING ACTIVITIES          
Net loss  $(1,794,073)  $(4,116,595)
Items not involving cash:          
Depreciation – property and equipment   18,796    19,367 
Impairment on long term investments   596,324     
Impairment on amount due from related parties   21,864     
Impairment on amount due from associate company   150,535     
Issuance of employee equity incentive plan       3,409,604 
Property, plant and equipment written off   3,327     
Changes in operating assets and liabilities          
Accounts Receivable   (507)   1,944 
Other receivables, prepayments and other current assets   (33,055)   (1,124)
Inventories   8,130    26,496 
Amount due from associated company       (112,119)
Amount due from related parties       12,216 
Accounts Payable   (13,454)   377 
Commission payables   (6,597)   30,808 
Accrued expense and other payables   (127,027)   162,508 
Net cash used in from operating activities   (1,175,737)   (566,518)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Amount due from associated company   (47,511)    
Purchase of long term investments   (596,324)    
Purchase of property and equipment   (582)   (39,216)
Net cash used in investing activities   (644,417)   (39,216)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds (repayments) from directors   (40,491)   3,683 
Proceeds from related parties   3,238,095    620,254 
Net cash provided by financing activities   3,197,604    623,937 
           
EFFECT OF EXCHANGE RATES ON CASH   106,521    46,843 
           
NET CHANGE IN CASH AND CASH EQUIVALENTS   1,483,971    65,046 
           
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD   691,199    105,432 
           
CASH AND CASH EQUIVALENTS, END OF PERIOD  $2,175,170   $170,478 
           
SUPPLEMENTAL OF CASH FLOW INFORMATION          
           
Cash paid for interest expenses  $   $ 
Cash paid for income tax  $   $ 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 6

 

 

VITAXEL GROUP LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(In U.S. dollars)

 

1. ORGANIZATION AND BUSINESS

 

Vitaxel Group Limited (the “Company” or “Vitaxel”), incorporated in Nevada, is engaged in direct selling industry and online shopping platform primarily through its operating entities in Malaysia.

 

Vitaxel SDN BHD (“Vitaxel SB”), was incorporated in Malaysia on August 10, 2012 and 100% owned by the Company. It is primarily engaged in the direct selling industry utilizing a multi-level marketing model with an emphasis on travel, entertainment and lifestyle products and services.

 

Vitaxel Online Mall SDN BHD (“Vionmall”), was incorporated in Malaysia on September 22, 2015 and 100% owned by the Company. It is primarily in developing online shopping platforms geared to Vitaxel and its members and the third-party suppliers of products and services.

 

Vitaxel Singapore PTE. Ltd. (“Vitaxel Singapore”) was incorporated in Singapore on February 16, 2016. This subsidiary was disposed on August 21, 2017.

 

2. UNAUDITED INTERIM FINANCIAL STATEMENTS

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information under Article 8 of Regulation S-X. They do not include all information and foot notes required by U.S. GAAP for complete financial statements. Except as disclosed herein, there have been no material changes in the information disclosed in the notes to the consolidated financial statement for the year ended December 31, 2017, included in the Company’s Form 10-K filed with the SEC. The interim unaudited consolidated financial statements should be read in conjunction with those audited consolidated financial statements included in Form10-K.

 

In the opinion of management, the Company has made all adjustments necessary to present a fair statements of the financial position as of September 30, 2018, results of operations for the three and nine months ended September 30, 2018 and 2017, and cash flows for the nine months ended September 30, 2018 and 2017. All significant intercompany transactions and balances are eliminated on consolidation. The results of operations for the nine months ended September 30, 2018 are not necessarily indicative of the results of operations for the entire fiscal year.

 

Recent Pronouncements

 

From time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. The Company believes that the impact of recently issued standards that are not yet effective may have an impact on our results of operations and financial position.

 

In February 2016, the FASB issued ASU No. 2016-02, Leases, to improve financial reporting about leasing transactions. This ASU will require organizations that lease assets (“lessees”) to recognize a lease liability and a right-of-use asset on its balance sheet for all leases with terms of more than twelve months. A lease liability is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis and a right-of-use asset represents the lessee’s right to use, or control use of, a specified asset for the lease term. The amendments in this ASU simplify the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. This ASU leaves the accounting for the organizations that own the assets leased to the lessee (“lessor”) largely unchanged except for targeted improvements to align it with the lessee accounting model and Topic 606, Revenue from Contracts with Customers. ASU No. 2016-02 is effective for reporting periods beginning after December 15, 2018. We do not expect the adoption of this guidance to have an impact on our consolidated financial statements.

 

 7

 

 

In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments”. The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. ASU 2016-15 is effective for the Company beginning in the first quarter of fiscal 2019. Early adoption is permitted, provided that all of the amendments are adopted in the same period. The guidance requires application using a retrospective transition method. The Company is currently evaluating the impact of adopting this guidance.

 

On May 10, 2017, the Financial Accounting Standards Board (“FASB”) issued an Accounting Standards Update (“ASU”) 2017-09 “Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting”, which provides guidance to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. The guidance is effective prospectively for all companies for annual periods beginning on or after December 15, 2017. Early adoption is permitted. The adoption of this guidance had no impact on its consolidated financial statements.

 

In August 2018, the FASB issued ASU 2018-13, Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which improves fair value disclosure requirements by removing disclosures that are not cost beneficial, clarifying disclosures’ specific requirements and adding relevant disclosure requirements. This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted and an entity can choose to early adopt any removed or modified disclosures upon issuance of this ASU and delay adoption of the additional disclosures until their effective date. The Company is still evaluating the impact that the adoption of ASU 2018-13 will have on the condensed consolidated financial statements and has not yet decided whether or not to early adopt the amendments.

 

Revenue Recognition

 

Effective January 1, 2018, the Company recognizes revenue pursuant to FASB Accounting Standards Codification 606 (“ASC 606”)  Revenue from Contracts with Customers , the standard applies five step model (i) The standard applies to a company’s contracts with customers (ii) The unit of account for revenue recognition under the new standard is a performance obligation (a good or service) and the performance obligations will be accounted for separately if they are distinct (iii) The transaction price is determined based on the amount of consideration that a company expects to be entitled to from a customer (iv) The transaction price is allocated to all the separate performance obligations in an arrangement, and (v) Revenue will be recognized when an entity satisfies each performance obligation by transferring control of the promised goods or services to the customer. Goods or services can transfer at a point in time or over time.

 

Product sales − The Company recognizes revenue when it satisfies each performance obligation by transferring control of the goods to the independent members or purchasers of the products. Product sales are recognized net of product returns, discounts and taxes. A reserve for product returns is accrued based on historical experience. There was no deferred revenue accrued as of September 30, 2018.

 

Membership fee − The Company recognizes the membership fee revenue over the term of the membership, which is 12 months. The revenue will not be recognized until the 10 days cooling-off period is expired.

 

ASC was adopted January 1, 2018 and applied using the partial retrospective method. There was no impact from the adoption of ASC 606 on the Company’s accounting for revenue.

 

 3. GOING CONCERN

 

These unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future.

 

For the period ended September 30, 2018, the Company reported a net loss of $1,794,073 and negative working capital of $3,813,065. The Company had an accumulated deficit of $8,870,547 as of September 30, 2018 due to the fact that the Company incurred losses during the years prior to September 30, 2018.

 

The continuation of the Company as a going concern is dependent upon improving the profitability and the continuing financial support from its stockholders or other capital sources. Management believes that the continuing financial support from the existing shareholders or external debt financing will provide the additional cash to meet the Company’s obligations as they become due.

 

These consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of the Company’s ability to continue as a going concern.

 

 8

 

    

 

4. OTHER RECEIVABLES, PREPAYMENTS AND OTHER ASSETS

 

Other receivables, prepayments and other assets consist of the following:

 

    September 30,
2018
   December 31,
2017
 
Deposits (1)   $26,243   $11,157 
Prepayments (2)    50,624    1,679 
Others (3)    493    31,469 
    $77,360   $44,305 

 

(1)         Deposits represented payments for rental, utilities, and valuer’s retainer fees.

(2)         Prepayments mainly consists of prepayment for inventories, insurance, consultancy fee and IT related fees.

(3)         Others mainly consists other miscellaneous payments

 

5. LONG-TERM INVESTMENTS

 

Long-term investment consists of the following:

 

   September 30, 2018   December 31, 2017 
Investment in associated companies          
Vitaxel Corporation Thailand Co., Ltd (1)          
Cost  $27,539   $27,539 
Share of loss in investment in an associated company   (25,716)   (25,716)
Foreign currency translation adjustment   (1,823)   (1,823)
Total investment in associated companies        
           
Other long-term investments          
Ho Wah Genting Group Ltd (2)          
Cost  $638,786   $ 
Impairment on carrying amount   (596,324)    
Foreign currency translation adjustment   (42,462)    
Total other long-term investments  $   $ 
Total Long-Term Investments  $   $ 

 

  (1)

On April 20, 2016, the Company invested 958,000 Thai Baht or $27,539 to Vitaxel Corporation Thailand Co., Ltd., a company registered in Thailand, and holds 47.99% shares of it. The long-term investment is accounted using the equity method.

 

The Company entered into a Sale and Purchase Agreement dated July 2, 2018 to sell the all the total and outstanding shares of Vitaxel Corp (Thailand) Co. Ltd. for total proceeds of $10,000. The disposal has been completed as of the date of this report.

 

As of September 30, 2018, the Company has provided impairment on the amount due from Vitaxel Corporation Thailand Co., Ltd of $150,535.

 

  (2)

During the first quarter of 2018, the Company acquired 7,663,246 shares of common stock of Ho Wah Genting Group Limited (“HWGG”), which is listed on the U.S. OTC (Pink) Market (stock code: HWGG), for consideration of MYR2,466,993 (approximately US$638,786 as calculated at the date of transaction), from certain shareholders of HWGG. This resulted in ownership by the Company of approximately 1.53% of HWGG

 

The President of the Company, Dato’ Lim Hui Boon, is also the President of HWGG.

 

In the absence of active market participants and liquidity for HWGG stock based on the review of the trading history of this stock, management concluded that there is no active market for the stock. The Company does not rely on quoted market prices since the HWGG stock is highly illiquid and inactive and said prices are not necessarily indicative or representative of fair market value of HWGG stock. Thus the management deemed that the stock has no readily determinable fair value.

 

As of period ended September 30, 2018, the Company has carried the investment in HWGG at its cost minus impairment.

 9

 

  

6. PROPERTY AND EQUIPMENT,  NET

 

Property and equipment, net consist of the following:

 

   September 30,
2018
   December 31,
2017
 
         
Office equipment  $36,226   $36,471 
Computer equipment   104,860    102,862 
Furniture and fittings   7,592    7,978 
Electrical & fitting       375 
Motor vehicle   16,602    16,983 
Software and website   14,221    11,580 
Renovations   102,863    108,860 
    282,364    285,109 
Less: Accumulated depreciation   (72,847)   (54,051)
Balance at end of period/year  $209,517   $231,058 

 

Depreciation expenses charged to the statements of operations and comprehensive loss for the periods ended September 30, 2018 and 2017 were $18,796 (3 months $4,371) and $19,367 (3 months $8,468) respectively.

 

7. ACCRUED EXPENSE AND OTHER PAYABLES

 

Accrued expense and other payables consist of the following:

 

   September 30,
2018
   December 31,
2017
 
         
Provisions and accruals  $45,626   $148,326 
Others (1)   320,160    344,487 
Balance at end of period/year  $365,786   $492,813 

 

(1)Other payables mainly consist of members allocated redemption points for commissions.

 

 10

 

 

8. RELATED PARTY BALANCES AND TRANSACTIONS

 

   September 30,
2018
   December 31,
2017
 
Amount due from related parties          
Ho Wah Genting Berhad (1)  $5,076   $ 
Ho Wah Genting Group Sdn Berhad (2)   257,473    18,149 
Beedo Sdn Bhd (3)       14,837 
Balance at end of year  $262,549   $32,986 
           
Amount of due from an associated company          
Vitaxel Corporation (Thailand) Limited (4)  $   $103,024 
Balance at end of year       103,024 
Total Amount due from related parties  $262,549   $136,010 
           
Amount of due to related parties          
Dato’ Lim Hui Boon (5)  $   $40,491 
Ho Wah Genting Holiday Sdn Bhd (6)   2,197    1,703 
Genting Highlands Taxi Services Sdn Bhd (7)       11,820 
VSpark Malaysia Sdn Bhd (8)   29    4,967 
Grande Legacy Inc. (9)   5,816,807    2,311,022 
Balance at end of year   5,819,034    2,370,003 
Total Amount due to related parties  $5,819,034   $2,370,003 

 

The related party balances are unsecured, interest-free and repayable on demand.

 

  (1) The President of the Company, Dato’ Lim Hui Boon, is also the Group President of Ho Wah Genting Berhad (“HWGB”), a company listed in Bursa Malaysia Main Market.

 

The Company recognized rent expenses of $15,208 (2017 - $9,635) to HWGB for the nine months ended September 30, 2018.

 

The Company has lease commitment under an operating lease for its corporate office facility with HWGB. The lease expires by December 31, 2018 and the remaining commitment for fiscal 2018 is $5,069.

 

  (2) The President of the Company, Dato’ Lim Hui Boon, is also the Group President of Ho Wah Genting Group Sdn Berhad (“HWGGSB”), a subsidiary of HWGG.

 

  (3) The President of the Company, Dato’ Lim Hui Boon, is a major shareholder of Beedo SDN BHD, holding 51% of share interest.

 

The Company recognized website maintenance expenses of $nil (2017 - $51,553) to Beedo SDN BHD for the nine months ended September 30, 2018.

 

  (4) The Company recognized product sales of $nil (2017 - $440,000) to an associated company, Vitaxel Corp. (Thailand) Limited for the nine months ended September 30, 2018.

 

  (5) The amount due to the President of the Company, Dato’ Lim Hui Boon, as at December 31, 2017 were advances made to the Company.

 

 11

 

 

  (6) A former director of the Company, Lim Chun Hoo, is also a director of Ho Wah Genting Holiday Sdn Bhd. On March 31, 2017, Lim Chun Hoo has resigned from the Company.

 

  (7) A director of the Company, Lim Wee Kiat, is also a director of Genting Highlands Taxi Services Sdn Bhd.

 

  (8) A director of a subsidiary (Vitaxel Online Mall Sdn Bhd), Liew Jenn Lim, is also a director of VSpark Malaysia Sdn Bhd.

 

The Company has engaged with VSpark Malaysia Sdn Bhd during the year for marketing purposes. There were no transactions during the period.

 

  (9) A director of the Company, Leong Yee Ming, is also a director of Grande Legacy Inc.

 

On January 5, 2017, the Company executed a license agreement with Grande Legacy Inc (“GL”). The agreement grants GL exclusive use of Vitaxel Marks to operate a Vitaxel business in countries other than Malaysia, Singapore and Thailand. However, GL is still in the process of obtaining online payment gateway for its credit card sales, GL is currently engaging Vitaxel SB to collect credit card sales proceeds on behalf.

 

On July 1, 2018, the Company signed an amendment to licensing agreement with GL, providing the revised terms of royalty payment. GL shall pay the Company royalty equal to 55% of net profits on a quarterly basis, commencing July 1, 2018. During the nine months ended September 30, 2018, the Company recognized $nil royalty income due GL incurring losses for the 3 months ended September 30, 2018.

 

On July 1, 2018, Vitaxel SB has entered into a management and administrative services agreement with GL. The agreement is to provide certain management and administrative support services for the operation of GL. For these services, Vitaxel SB shall charge a monthly management fee of $40,000 to GL. The Company recognized management fee income of $120,000 charged to GLfor the nine months ended September 30, 2018.

 

During the nine months ended September 30, 2018, the Company incurred general and administrative expenses of $295,647 related to the operations of GL for no fee.

 

9. SHAREHOLDERS’ EQUITY

 

There were no share issuances during the nine months ended September 30, 2018.

 

10. PROPOSED TRANSACTIONS

 

The Company entered into a Share Sale Agreement (the “Agreement”) effective December 15, 2017 with Lim Hui Sing and Leong Yee Ming (together, the “Sellers”) and Vitaxel SB (the “Purchaser”), as previously described in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 19, 2017 as amended on January 3, 2018 and June 11, 2018. Pursuant to the terms of the Agreement, the Sellers will sell to the Purchaser all their shares in GL, a British Virgin Islands company, resulting in the Company becoming the indirect owner of all of the issued and outstanding shares of the capital stock of GL. In consideration for such sale, the Company agreed to issue to the Sellers an aggregate of 75,000,000 shares of the Company.

 

On January 3, 2018 the parties to the Agreement executed and delivered an amendment (the “Amendment”) to the Agreement which provided that the acquisition of GL shall close upon satisfaction of both of the following conditions:

 

i. The completion of the financial statements of GL being audited; and

ii.The issuance of 75,000,000 shares of the Company to the Sellers within 30 days of the Company obtaining shareholder approval of the amendment to the Articles of Incorporation of the Company for increasing the amount of authorized shares.

 

On September 21, 2018, the Company received legal letter from the shareholders of GL to terminate the acquisition agreement and alleging that the Company exceeded its time to satisfy said conditions, which were to be completed by June 15, 2018.

 

As at date of this report, the Company is still exploring its legal rights in the above transaction and whether it wishes to pursue said rights or remedies.   

 

 12

 

 

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Statement Regarding Forward-Looking Information

 

The following management’s discussion and analysis should be read in conjunction with the historical financial statements and the related notes thereto contained in this report. The management’s discussion and analysis contains forward-looking statements, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. The Company’s actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors. The Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this report.

 

The following discussion highlights the Company’s results of operations and the principal factors that have affected our financial condition, as well as our liquidity and capital resources for the periods described, and provides information that management believes is relevant for an assessment and understanding of the statements of financial condition and results of operations presented herein. The following discussion and analysis are based on the Company’s unaudited financial statements contained in this Quarterly Report, which we have prepared in accordance with United States generally accepted accounting principles. You should read this discussion and analysis together with such financial statements and the related notes thereto.

 

As used in this Quarterly Report, the terms “we,” “us,” “Company,” and “our” mean Vitaxel Group Limited and its subsidiaries on a consolidated basis, unless otherwise indicated or the context requires otherwise.

 

Overview; Recent Events

 

We are a global direct selling, multi-level marketing (“MLM”) company offering travel, entertainment, lifestyle and other products and services principally through electronic commerce commonly referred to as e-commerce. Through Vionmall, which went live in January 2016 for Vitaxel members and April 2016 for general public, we employ online shopping web sites for retail sales direct to consumers. We do not develop or manufacture the products and services which we offer. Our principal offices are located in Kuala Lumpur, Malaysia.

 

Unlike the traditional MLM business model where most of the business model concentrates on particular products and/or services, our business model allows our members to own a sub-domain through Vionmall where they can promote their own products and services (separate from our products and services). We believe that this model is the first of its kind in Asia.

 

As of September 30, 2018, we had approximately 8,217 total members in Malaysia, Thailand and Singapore.

 

While sales within our local markets may fluctuate due to economic, market and regulatory conditions, competitive pressures, political and social instability or for Company-specific reasons, we believe that our geographic diversity and intended further geographic diversity mitigates and will continue to mitigate our exposure to any one particular market.

 

Termination of Legacy Transaction

The Company entered into a Share Sale Agreement (the “Agreement”) effective December 15, 2017 with Lim Hui Sing and Leong Yee Ming (together, the “Sellers”) and Vitaxel SB (the “Purchaser”), as previously described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on December 19, 2017 as amended on January 3, 2018 and June 11, 2018. Pursuant to the terms of the Agreement, the Sellers were to sell to Purchaser all their shares of Grand Legacy, Inc., a British Virgin Islands company (“GL”), which would have resulted in the Company becoming the indirect owner of all of the issued and outstanding shares of the capital stock of GL. The closing of the transaction was to occur upon completion of the financial statements of GL being audited and the issuance of 75,000,000 consideration shares to sellers within 30 days of shareholder approval of the amendment to the Company’s Articles of Incorporation increasing our capitalization.

 

On September 21, 2018, the Company received legal letter from the shareholders of GL declaring the agreement terminated, and alleged that the Company exceeded its allotted time to satisfy the closing conditions.

 

While the Company’ disagrees with GL’s assessment, as at date of this Report, the Company has not made a final determination as to what actions it will take, if any, or whether it would like to allow the foregoing transaction to terminate.

 

Results of Operations –Three Months Ended September 30, 2018 Compared to Three Months Ended September 30, 2017

 

The following discussion should be read in conjunction with our unaudited consolidated financial statements in Item 1, Financial Statements, for the three months ended September 30, 2018 and 2017 and the related notes thereto.

 

Revenue

 

We recognized $8,250 and $13,803 revenues for the periods ended September 30, 2018 and 2017, respectively. The decrease in revenue is attributable to a decrease in our sales due to fewer customers in the current period compared to the same period last year.

 

Cost of Sales

 

Cost of sales for the period ended September 30, 2018 was $3,859 compared to $7,389 for the period ended September 30, 2017. The decrease is comparable to the decrease of revenue and attributable to lower sales.  

 

Gross Profit

 

Gross profit for the period ended September 30, 2018 was $4,391 compared to $6,414 for the period ended September 30, 2017. The decrease is attributable to the lower revenue for the current period as compared to the same period last year.

 

 13

 

 

Operating Expenses

 

For the period ended September 30, 2018, we incurred total operating expenses in the amount of $325,411, composed of selling expenses of -$151 and general and administrative expenses totaling $325,562. Whilst, for the period ended September 30, 2017, we incurred total operating expenses in the amount of $291,041 which was composed of selling expenses of $433 and general and administrative expenses totaling 290,608. The decrease of $584 or 135% for the selling expenses, along with the decrease of $34,954 or 12% for the administrative expenses, caused total operating expenses to decrease by $34,954 or 12%.

 

Results of Operations –Nine Months Ended September 30, 2018 Compared to Nine Months Ended September 30, 2017

 

The following discussion should be read in conjunction with our unaudited consolidated financial statements in Item 1, Financial Statements, for the nine months ended September 30, 2018 and 2017 and the related notes thereto.

 

Revenue

 

We recognized $31,338 and $554,149 revenues for the periods ended September 30, 2018 and 2017, respectively. The decrease in revenue is attributable to a decrease in our sales due to fewer customers in the current period compared to the same period last year.

 

Cost of Sales

 

Cost of sales for the period ended September 30, 2018 was $10,929 compared to $185,146 for the period ended September 30, 2017. The decrease is comparable to the decrease of revenue and attributable to lower sales.

 

Gross Profit

 

Gross profit for the period ended September 30, 2018 was $20,409 compared to $369,003 for the period ended September 30, 2017. The decrease is attributable to the lower revenue for the current period as compared to the same period last year.

 

Operating Expenses

 

For the period ended September 30, 2018, we incurred total operating expenses in the amount of $1,256,362, composed of selling expenses of $7,244 and general and administrative expenses totaling $1,249,118. Whilst, for the period ended September 30, 2017, we incurred total operating expenses in the amount of $4,504,793 which was composed of selling expenses of $691 and general and administrative expenses totaling $4,514,102. The increase of $6,553 or 948% for the selling expenses, along with the decrease of $3,254,984 or 72% for the administrative expenses, caused total operating expenses to decrease by $3,248,431 or 72%. In 2017, the Company issue 3,100,290 common shares under the Equity Incentive Plan as bonus for its employee and this result in $3,409,604 expense to be absorbed by the Company.

 

Liquidity and Capital Resources

 

As of September 30, 2018, we had a cash balance of $2,175,170. During the period ended September 30, 2018, net cash used in operating activities totaled $1,175,737. Net cash used in investing activities totaled $644,417. Net cash provided by financing activities during the period totaled $3,197,604. The resulting change in cash for the period was an increase of $1,483,971, which was primarily due to related parties proceeds during the period.

 

As of September 30, 2018, we had current liabilities of $6,349,046, which was composed of amount due to related parties of $5,819,034, commission payables of $146,274, accounts payable of $17,952 and accruals and other payable of $365,786. 

 

As of September 30, 2017, we had a cash balance of $170,478. During the period ended September 30, 2017, net cash used in operating activities totaled $566,518. Net cash used in investing activities totaled $39,216. Net cash provided by financing activities during the period totaled $623,937. The resulting change in cash for the period was an increase of $65,046, which was primarily due to related parties proceeds during the period.

 

As of December 31, 2017, we had current liabilities of $3,047,093, which was composed of amount due to related parties of $2,370,003, commission payables of $152,871, accounts payable of $31,406 and accruals and other payables of $492,813.

 

We had net liabilities of $3,603,548 and $1,915,996 as of September 30, 2018 and December 31, 2017, respectively.

 

Management estimates that the general operating costs for the next 12 months will be approximately $1,500,000. At present, the Company may not have sufficient capital resources to meet its anticipated operating and capital requirements for the next 12 months. The Company anticipates receiving royalty payments from its licensees starting the last quarter of 2018. Management is also evaluating other options, including obtaining financing through private placements, charging licensees administration fees, and entering additional licensing agreements. The Company will continue to monitor the current economic and financial market conditions and evaluate their impact on the Company’s liquidity and future prospects.

 

 14

 

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits.

 

Critical Accounting Policies and Estimates

 

There are no material changes from the critical accounting policies set forth in “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. Please refer to Note 2 Summary of Significant Accounting Policies of the Financial Statements for disclosures regarding the critical accounting policies related to our business.

 

Contractual Obligations

 

Not applicable.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management including our principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosures. Based upon their evaluation of those controls and procedures performed as of the end of the period covered by this report, our principal executive and principal financial officers concluded that our disclosure controls and procedures were not effective in ensuring that: (i) information required to be disclosed by us in reports that we file or submit to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in applicable rules and forms and (ii) material information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for accurate and timely decisions regarding required disclosure.

 

As required by Rule 13a-15(e), our management has carried out an evaluation, with the participation and under the supervision of Leong Yee Ming, our Chief Executive Officer (“CEO”), and Lim Wee Kiat, our Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of our disclosure controls and procedures, as of September 30, 2018. Based upon their participation in that evaluation, the CEO and CFO concluded that the control deficiency over financial reporting identified during the previous period has been remediated and the disclosure controls and procedures were effective as of September 30, 2018.

 

Changes in Internal Controls

 

During the fiscal quarter ended September 30, 2018, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

 

 15

 

 

PART II - OTHER INFORMATION

 

ITEM 1.LEGAL PROCEEDINGS

 

As of the date of this Quarterly Report, our management is not aware of any proceedings to which any of our directors, officers, or affiliates, or any associate of any such director, officer, affiliate, or security holder is a party adverse to our company or has a material interest adverse to us.

 

ITEM 1A.RISK FACTORS

 

The company is necessarily subject to a number of risks which should be considered when reviewing this Quarterly Report. Some of the risks relating to the Company are set forth in our Annual Report on Form 10K for the period ended December 31, 2017, which should be reviewed in conjunction herewith.

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Not applicable.

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5.OTHER INFORMATION

 

Not applicable.

 

 16

 

 

ITEM 6.  EXHIBITS

   

The following exhibits are included as part of this report:

 

Exhibit
Number
  Description of Exhibit
31.1   Certification of Principal Executive Officer and Pursuant to Rule 13a-14
31.2   Certification of Principal Financial Officer Pursuant to Rule 13a-14
32.1   CEO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act
32.2   CFO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema Document
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB   XBRL Taxonomy Extension Labels Linkbase Document
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document

 

 17

 

 

SIGNATURES

 

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

 

  VITAXEL GROUP LIMITED
   
November 14, 2018 By: /s/ Leong Yee Ming
  Leong Yee Ming, Chief Executive Officer (principal executive officer)
   
  VITAXEL GROUP LIMITED
   
November 14, 2018 By: /s/ Lim Wee Kiat
  Lim Wee Kiat, Chief Financial Officer (principal financial and accounting officer)
     

 18